Volume 19, Issue 10, Pages (June 2017)

Slides:



Advertisements
Similar presentations
Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.
Advertisements

Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Volume 21, Issue 1, Pages (January 2012)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors  Anita Muthukaruppan, Annette Lasham,
Volume 11, Issue 6, Pages (May 2015)
Volume 21, Issue 11, Pages (December 2017)
Volume 5, Issue 1, Pages (October 2013)
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
Molecular Therapy - Nucleic Acids
Volume 20, Issue 13, Pages (September 2017)
Volume 20, Issue 7, Pages (August 2017)
Volume 12, Issue 12, Pages (September 2015)
Volume 4, Issue 5, Pages (May 2015)
Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade  Florian Rambow, Audrey Bechadergue, Flavie Luciani, Gwendoline Gros, Melanie.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 5, Issue 6, Pages (December 2013)
Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer
Volume 8, Issue 6, Pages (June 2017)
Volume 6, Issue 5, Pages (March 2014)
Volume 14, Issue 12, Pages (March 2016)
Volume 24, Issue 11, Pages (June 2014)
Volume 23, Issue 11, Pages (June 2018)
Volume 8, Issue 4, Pages (April 2017)
Volume 15, Issue 9, Pages (May 2016)
Katja Lundgren, Nicholas P
Volume 53, Issue 5, Pages (March 2014)
Transcriptional Landscape of Cardiomyocyte Maturation
Volume 13, Issue 2, Pages (October 2015)
Volume 25, Issue 3, Pages (March 2017)
Volume 4, Issue 3, Pages (August 2013)
Volume 21, Issue 1, Pages (January 2012)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 9, Issue 3, Pages (September 2017)
S. D'Adamo, O. Alvarez-Garcia, Y. Muramatsu, F. Flamigni, M.K. Lotz 
Volume 43, Issue 5, Pages (September 2011)
Volume 21, Issue 11, Pages (December 2017)
Volume 24, Issue 12, Pages e5 (September 2018)
Shi-Yan Ng, Gireesh K. Bogu, Boon Seng Soh, Lawrence W. Stanton 
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Volume 5, Issue 1, Pages 1-9 (July 2015)
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Volume 9, Issue 5, Pages (November 2017)
Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes
Volume 5, Issue 5, Pages (November 2015)
Volume 23, Issue 1, Pages (April 2018)
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity  Thomas G. Fazzio, Jason T. Huff, Barbara Panning 
Volume 25, Issue 4, Pages (April 2017)
Volume 15, Issue 11, Pages (June 2016)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 20, Issue 13, Pages (September 2017)
Volume 7, Issue 1, Pages (July 2016)
Volume 15, Issue 12, Pages (June 2016)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 17, Issue 3, Pages (October 2016)
Volume 20, Issue 13, Pages (September 2017)
Molecular Therapy - Nucleic Acids
Volume 9, Issue 4, Pages (October 2017)
Volume 18, Issue 11, Pages (March 2017)
Volume 24, Issue 10, Pages (October 2016)
Volume 53, Issue 5, Pages (March 2014)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes
Volume 25, Issue 12, Pages e4 (December 2018)
Volume 26, Issue 11, Pages e6 (March 2019)
Volume 24, Issue 11, Pages (June 2014)
Molecular Therapy - Nucleic Acids
Presentation transcript:

Volume 19, Issue 10, Pages 2026-2032 (June 2017) MicroRNA-Mediated Dynamic Bidirectional Shift between the Subclasses of Glioblastoma Stem-like Cells  Arun K. Rooj, Franz Ricklefs, Marco Mineo, Ichiro Nakano, E. Antonio Chiocca, Agnieszka Bronisz, Jakub Godlewski  Cell Reports  Volume 19, Issue 10, Pages 2026-2032 (June 2017) DOI: 10.1016/j.celrep.2017.05.040 Copyright © 2017 The Author(s) Terms and Conditions

Cell Reports 2017 19, 2026-2032DOI: (10.1016/j.celrep.2017.05.040) Copyright © 2017 The Author(s) Terms and Conditions

Figure 1 MiR-128 Expression Drives GSC Subtype Shift (A) MiR-128 is diversely expressed in GSC subclasses. Shown is qPCR analysis of mature miR-128 in GSCs (n = 8). Data are shown as mean ± SD (∗∗p < 0.001). (B) Putative miR-128 targets are diversely expressed in GSCs subclasses. 5,666 putative miR-128 target genes were assessed based on the value of expression (p < 0.05, fold > 2 cutoff is indicated) (left). The expression of miR-128 putative target genes in GSCs stratifies P from M GSCs (n = 3). Targets significantly deregulated in M GSCs (n = 569) and P GSCs (n = 741) were queried with a gene signature retrieved from TCGA and identified by clustering with subtype prediction (classical [C], blue; mesenchymal [M], red; proneural [P], magenta; neural [N], green) (right). (C) Engineered GSCs with overexpression and knock-down of miR-128. Shown is qPCR analysis of mature miR-128 in GSCs (n = 3). Data are shown as ± SD (∗∗p < 0.001) (left). Deregulation of miR-128 in GSCs shifts the subtype-specific gene signature. Shown is qPCR analysis of subtype-specific ten-gene signatures in M GSCs (center) and P GSCs (right). Data are shown as a heatmap with cell and gene clustering. NC, negative control (empty pCDH); 128, overexpression of miR-128 (pCDH-miR-128); aNC, negative control (empty MIR-ZIP); a128, knockdown of miR-128 (MIR-ZIP-anti-miR-128). (D) Deregulation of miR-128 shifts GSC transcriptome clustering. Shown is gene microarray analysis of 3,017 genes significantly (p < 0.05, fold > 2) deregulated in GSCs (n = 3) in an miR-128-dependent fashion. Data are shown as a heatmap with cell clustering (left) and as a principal-component analysis (PCA) (center). The expression of genes deregulated by miR-128 in GSCs results in a transitional signature resembling the classical subtype. Targets significantly deregulated in M and P GSCs (n = 3,017) were queried with a gene signature retrieved from TCGA and identified by clustering with subtype prediction (n = 485, overall error rate > 0.05) (C, blue; M, red; P, magenta; N, green) (right). Cell Reports 2017 19, 2026-2032DOI: (10.1016/j.celrep.2017.05.040) Copyright © 2017 The Author(s) Terms and Conditions

Figure 2 PRC Proteins and Their Effectors Are miR-128-Dependent Controllers of GSC Subtype Shift (A) MiR-128 deregulation affects the expression of PRCs, their chromatin marks, and PRC-dependent genes in GSCs. Shown is Western blot analysis of selected factors in control and miR-128 de-regulated GSCs (n = 3). (B) Expression of PRC-dependent genes is shifted by miR-128. Shown is microarray platform analysis of a 30-PRC-dependent gene signature in control and miR-128 de-regulated GSCs. Data are shown as a heatmap with cell and gene clustering (n = 3). (C) Expression of PRC-dependent genes is diversely shifted by Bmi1/Suz12 knockdown and miR-128. Shown is microarray platform analysis of a 30-PRC-dependent gene signature in control, miR-128-overexpressing, and Bmi1/Suz12 siRNA-transfected M GSCs. Data are shown as a heatmap with cell and gene clustering (n = 3). (D) Bmi1/Suz12 knockdown deregulates the GSC transcriptome in a subtype-dependent manner. Shown is gene microarray analysis of genes significantly (p < 0.05, fold > 2) deregulated in GSCs in a Bmi1/Suz12-dependent fashion (n = 3). Data are shown as a heatmap with cell and gene clustering (left) and as a PCA (center). The expression of genes deregulated by Bmi1/Suz12 knockdown in M GSCs results in a transitional signature resembling the classical subtype. Genes significantly deregulated in M and P GSCs (n = 937) were queried with a gene signature retrieved from TCGA and identified by clustering with subtype prediction (n = 380, overall error rate > 0.05) (right). Cell Reports 2017 19, 2026-2032DOI: (10.1016/j.celrep.2017.05.040) Copyright © 2017 The Author(s) Terms and Conditions

Figure 3 MiR-128 Mitigates the Aggressive Phenotype of M GSCs Both In Vivo and In Vitro (A) MiR-128 overexpression reduces the M GSC tumor burden. Shown are MRI (left; scale bar, 2.5 mm) and tumor volume quantification (right) (n = 3). Data are mean ± SD. ∗∗p < 0.01. (B) MiR-128 overexpression in M GSC tumors is associated with prolonged survival. Median survival: M GSC control, 11 days; M GSC miR-128, 16 days. n = 8 mice/group. (C) MiR-128 targets PRCs’ components in vivo. Shown is western blot analysis of M GSC cells (day 0) and in M GSC tumors (day 10) (left). Also shown are western blot quantification (center, n = 3) and qPCR analysis of miR-128 expression in tumors (day 10, right, n = 3). Data are mean ± SD. ∗p < 0.05, ∗∗p < 0.01. (D) MiR-128 overexpression shifts the subtype-specific gene signature in vivo. Shown is qPCR analysis of a ten-gene subtype-specific signature in M GSC tumors (left). MiR-128 overexpression shifts the expression of PRC-dependent genes in vivo. Also shown is microarray platform analysis of a 30-PRC gene signature in M GSC tumors (n = 3). Data are shown as a heatmap with cell/gene clustering (right). Cell Reports 2017 19, 2026-2032DOI: (10.1016/j.celrep.2017.05.040) Copyright © 2017 The Author(s) Terms and Conditions

Figure 4 Targets of miR-128 and miR-128-Dependent PRC-Associated Genes Predict Patient Outcome in GBM Subtypes (A) MiR-128 knockdown in P GSC tumors is associated with shorter survival. Micrographs of tumors (left) and survival (right) are shown. n = 4 or 5 mice/group. Average survival: P GSC control, 168 days; P GSC amiR-128, 143 days. Scale bars, 1 mm (top) and 200 μm (bottom). (B) Expression of miR-128 affects the survival of heterogeneous GSC-originated tumors. Micrographs of tumors (left) and survival (right) are shown. n = 4 mice/group. Average survival: M GSC miR-128/P GSC control, 19 days; M GSC miR-128/P GSC amiR-128, 9 days. Scale bars, 500 μm (top) and 50 μm (bottom). (C) The miR-128-dependent transcriptome separates patients’ survival prediction. Genes deregulated in GSCs queried with a TCGA gene signature were identified by clustering with class (top bar) and subtype (bottom bar) (left), miR-128 deregulated target genes (center; value of expression, p < 0.05, fold > 2, n = 43), and class survival prediction (right). (D) MiR-128 deregulation in M GSCs and P GSCs shifts the transcriptome toward a transitional hybrid classical-like subtype. Cell Reports 2017 19, 2026-2032DOI: (10.1016/j.celrep.2017.05.040) Copyright © 2017 The Author(s) Terms and Conditions